Synthesis and Antimicrobial Activity of the Hybrid Molecules between Sulfonamides and Active Antimicrobial Pleuromutilin Derivative

Chemical Biology and Drug Design

Volumn 86, Issue 2, 2015, Pages 239-245

  Chen, Liangzhu ^a,b   Yang, Dexue ^b   Pan, Zhikun ^a   Lai, Lihong ^b   Liu, Jianhua ^b   Fang, Binghu ^a,b   Shi, Shuning ^b  

^a Guangdong Dahuanong Animal Health Products Co Ltd   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

antibacterial activity; hybrid molecules; pleuromutilin derivative; sulfonamides

Indexed keywords

ANTIINFECTIVE AGENT; DITERPENE; PLEUROMUTILIN; SULFONAMIDE;

CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MYCOBACTERIUM; PROCEDURES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SYNTHESIS;

ANTI-INFECTIVE AGENTS; DITERPENES; DRUG DESIGN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SULFONAMIDES;

EID: 84947126215     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12486     Document Type: Article

References (17)

1. Wakatake H., Fujitani S., Kodama T., (2012) Positive clinical risk factors predict a high rate of methicillin-resistant Staphylococcus aureus colonization in emergency department patients. Am J Infect Control; 40: 988-991.
2. Guducuoglu H., Aktas E., Comert F.B., (2009) First isolation and detection of multiple clones of vancomycin-resistant enterococci in the pediatric unit of Van Yuzuncu Yil university, Turkey. Mikrobiyol Bul; 43: 535-543.
3. Kavanagh F., Herxey A., Robbins W.J., (1951) Antibiotic substance from basidiomycetes: VIII. pleurotus mutilus (Fr.) Sacc. and Pleurotus passeckerianus Pilat. Proc Natl Acad Sci USA; 37: 570-574.
4. Anchel M., (1952) Chemical studies with pleuromutilin. J Biol Chem; 199: 133-139.
5. Davidovich C., Bashan A., Yaggie R., Auerbach-Nevo T., Gontarek R.R., Yonath A., (2007) Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity. Proc Natl Acad Sci USA; 104: 4291-4294.
6. Egger H., Reinshagen H., (1976) New pleuromutilin derivatives with enhanced antimicrobial activity. I. Synthesis. J Antibiot; 29: 915-919.
7. Brooks G., Burgess W., Colthrust D., Hinks J.D., Hunt E., Pearson M.J., Shea B., Takle A.K., Wilson J.M., Woodnutt G., (2001) Pleuromutilins. Part 1: The identification of novel mutilin 14-carbamates. Bioorg Med Chem; 9: 1221-1231.
8. Egger H., Reinshagen H., (1976) New pleuromutilin derivatives with enhanced antimicrobial activity. J Antibiot; 29: 923-927.
9. Nieto M.J., Alovero F.L., Manzo R.H., Mazzieri M.R., (2005) Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies. Eur J Med Chem; 40: 361-369.
10. Bukvic K.M., Novak P., Cindric M., Brajsa K., Dumic M., Kujundzic N., (2007) Azithromycin-sulfonamide conjugates as inhibitors of resistant Streptococcus pyogenes strains. Eur J Med Chem; 42: 138-145.
11. Jazayeri S., Moshafi M.H., Firoozpour L., Emami S., Rajabalian S., Haddad M., Pahlavanzadeh F., Esnaashari M., Shafiee A., Foroumadi A., (2009) Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids. Eur J Med Chem; 44: 1205-1209.
12. Gaiying Z., Marvin J.M., Franzblau S., Baojie W., Mollmann U., (2006) Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents. Bioorg Med Chem Lett; 16: 5534-5537.
13. Hirokawa Y., Kinoshita H., Tanaka T., Nakamura T., Fujimoto K., (2008) Pleuromutilin derivatives having a purine ring. Part 1: New compounds with promising antibacterial activity against resistant Gram-positive pathogens. Bioorg Med Chem Lett; 18: 3556-3561.
14. Hirokawa Y., Kinoshita H., Tanaka T., Nakamura T., Fujimoto K., Kashimoto S., Kojima T., Kato S., (2009) Pleuromutilin derivatives having a purine ring. Part 2: Influence of the central spacer on the antibacterial activity against Gram-positive pathogens. Bioorg Med Chem Lett; 19: 170-174.
15. Biedenbach D.J., Jones R.N., Ivezic-schoenfeld Z., Paukne S., (2009) In Vitro Antibacterial spectrum of BC-7013, a Novel Pleuromutilin derivative for Topical use in humans. ICAAC; 49: F1-F1521.
16. Fazakerley N.J., Procter D.J., (2014) Synthesis and synthetic chemistry of pleuromutilin. Tetrahedron; 70: 6911-6930.
17. Mandal S., Moudgil M., Mandal S.K., (2009) Rational drug design. Eur J Pharmacol; 625: 90-100.